Legal & General Group
NERV icon

Legal & General Group’s Minerva Neurosciences NERV Stock Holding History

Legal & General Group’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4K Buy
+3,320
New +$18K ﹤0.01% 3160
2021
Q2 		– Sell
-509
Closed -$12K – 3596
2021
Q1 		$12K Hold
509
– – ﹤0.01% 3326
2020
Q4 		$10K Hold
509
– – ﹤0.01% 3345
2020
Q3 		$13K Sell
509
-122
-19% -$3.3K ﹤0.01% 3131
2020
Q2 		$18K Buy
631
+29
+5% +$1.7K ﹤0.01% 3106
2020
Q1 		$29K Sell
602
-90
-13% -$5.43K ﹤0.01% 2776
2019
Q4 		$39K Buy
692
+97
+16% +$4.28K ﹤0.01% 2918
2019
Q3 		$37K Hold
595
– – ﹤0.01% 2866
2019
Q2 		$27K Hold
595
– – ﹤0.01% 3079
2019
Q1 		$38K Hold
595
– – ﹤0.01% 2818
2018
Q4 		$32K Hold
595
– – ﹤0.01% 2879
2018
Q3 		$60K Hold
595
– – ﹤0.01% 2688
2018
Q2 		$40K Buy
595
+5
+0.8% +$304 ﹤0.01% 2861
2018
Q1 		$29K Sell
590
-367
-38% -$17.6K ﹤0.01% 2987
2017
Q4 		$47K Sell
957
-197
-17% -$9.77K ﹤0.01% 2888
2017
Q3 		$69K Buy
1,154
+252
+28% +$14.5K ﹤0.01% 2810
2017
Q2 		$63K Buy
902
+171
+23% +$11.1K ﹤0.01% 2834
2017
Q1 		$48K Buy
731
+2
+0.3% +$155 ﹤0.01% 2881
2016
Q4 		$69K Buy
729
+363
+99% +$37.1K ﹤0.01% 2770
2016
Q3 		$40K Hold
366
– – ﹤0.01% 2619
2016
Q2 		$30K Buy
+366
New +$23.3K ﹤0.01% 2737

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Legal & General Group's NERV Position: Q2 2026 in Review

Legal & General Group opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 3,320 shares worth $18.4K. The stake represents ﹤0.01% of the portfolio and ranks #3160 among its holdings. This is a return to the name: Legal & General Group previously reported a position in NERV as recently as Q1 2021.

Legal & General Group first reported a position in NERV in Q2 2016 and has held it in 21 quarters since. The position peaked at $69K in Q3 2017. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Legal & General Group held 3,320 shares of Minerva Neurosciences worth $18.4K as of Q2 2026.
  • Minerva Neurosciences was a new Legal & General Group position in Q2 2026.
  • Minerva Neurosciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3160 holding.
  • Legal & General Group first reported a position in Minerva Neurosciences in Q2 2016 and has held it in 21 quarters since.
  • Legal & General Group's Minerva Neurosciences position peaked at $69K in Q3 2017.
  • 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.